ATE327766T1 - Verfahren zur diagnose, feststellung, einstufung, darstellung sowie behandlung gynäkologischer krebserkrankungen - Google Patents

Verfahren zur diagnose, feststellung, einstufung, darstellung sowie behandlung gynäkologischer krebserkrankungen

Info

Publication number
ATE327766T1
ATE327766T1 AT99948349T AT99948349T ATE327766T1 AT E327766 T1 ATE327766 T1 AT E327766T1 AT 99948349 T AT99948349 T AT 99948349T AT 99948349 T AT99948349 T AT 99948349T AT E327766 T1 ATE327766 T1 AT E327766T1
Authority
AT
Austria
Prior art keywords
diagnosis
presentation
classification
detection
treatment
Prior art date
Application number
AT99948349T
Other languages
English (en)
Inventor
Shujath M Ali
Robert Cafferkey
Original Assignee
Diadexus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diadexus Inc filed Critical Diadexus Inc
Application granted granted Critical
Publication of ATE327766T1 publication Critical patent/ATE327766T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57545—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the ovaries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5755—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99948349T 1998-09-23 1999-09-23 Verfahren zur diagnose, feststellung, einstufung, darstellung sowie behandlung gynäkologischer krebserkrankungen ATE327766T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10152298P 1998-09-23 1998-09-23

Publications (1)

Publication Number Publication Date
ATE327766T1 true ATE327766T1 (de) 2006-06-15

Family

ID=22285082

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99948349T ATE327766T1 (de) 1998-09-23 1999-09-23 Verfahren zur diagnose, feststellung, einstufung, darstellung sowie behandlung gynäkologischer krebserkrankungen

Country Status (7)

Country Link
EP (1) EP1115426B1 (de)
JP (1) JP2002526055A (de)
AT (1) ATE327766T1 (de)
CA (1) CA2343918A1 (de)
DE (1) DE69931644T2 (de)
ES (1) ES2267291T3 (de)
WO (1) WO2000016805A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6902892B1 (en) 1998-10-19 2005-06-07 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
EP1646357A4 (de) * 2003-06-27 2007-01-10 Diadexus Inc Pro104 antikörper-zusammensetzungen und anwendungsverfahren
JPWO2005010180A1 (ja) * 2003-07-23 2006-09-07 北海道ティー・エル・オー株式会社 ホメオボックス遺伝子の発現による癌の判定方法
CA2550900A1 (en) * 2003-12-23 2005-07-07 Mount Sinai Hospital Methods for detecting markers associated with endometrial disease or phase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736377A (en) * 1995-06-06 1998-04-07 New England Medical Center Hospitals, Inc. NES-1 polypeptides, DNA, and related molecules and methods
US6479274B1 (en) * 1997-02-13 2002-11-12 Amrad Operations Pty., Ltd. DNA molecules encoding human HELA2 or testisin serine proteinases
CA2347906A1 (en) * 1998-08-04 2000-02-17 Diadexus, Inc. A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer
WO2000012758A1 (en) * 1998-09-02 2000-03-09 Diadexus Llc A novel method of diagnosing, monitoring, staging, imaging and treating various cancers

Also Published As

Publication number Publication date
ES2267291T3 (es) 2007-03-01
DE69931644T2 (de) 2007-05-10
EP1115426B1 (de) 2006-05-31
EP1115426A1 (de) 2001-07-18
CA2343918A1 (en) 2000-03-30
DE69931644D1 (de) 2006-07-06
WO2000016805A1 (en) 2000-03-30
EP1115426A4 (de) 2002-07-24
JP2002526055A (ja) 2002-08-20

Similar Documents

Publication Publication Date Title
ATE413466T1 (de) Verfahren zur diagnose, bewertung sowie bilddarstellung verschiedener krebserkrankungen
DE69929785D1 (de) Verfahren zur Diagnose, Erkennung, und Einstufung von Dickdarmkrebs
EP1578923A4 (de) Lösliche mic-polypeptide als marker zur diagnose, prognose und behandlung von krebs sowie autoimmunkrankheiten oder -erkrankungen
DE60233485D1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
WO2004067570A3 (en) Prostate cancer diagnosis and treatment
NO20013002L (no) Blandinger og fremgangsmåter for behandling og diagnose av ovariekreft
DE60325617D1 (de) Verfahren zur diagnose von bauchspeicheldrüsenkrebs
ATE345399T1 (de) Biomarker und targets für die diagnose, prognose und behandlung von prostat krankheiten
WO2004021008A3 (en) Methods for detecting breast and ovarian cancer
NO994932L (no) Blandinger og fremgangsmåter for behandling og diagnose av brystkreft
DE69510336D1 (de) Verfahren zur diagnose von praeklampsie
IL151448A0 (en) Proteins
WO2004021009A3 (en) Methods for detecting endocrine cancer using kallikrein 13 (klk13) as a biomarker
WO2001037779A3 (en) A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer
WO2004021010A3 (en) Method of diagnosing colon and gastric cancers
ATE327766T1 (de) Verfahren zur diagnose, feststellung, einstufung, darstellung sowie behandlung gynäkologischer krebserkrankungen
DE60038614D1 (de) Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungen
EP1107006A4 (de) Verfahren zur diagnose von knochenmetastasen und malignen tumoren
NO20014805D0 (no) Blandinger og fremgangsmåter for behandling og diagnose av brystkreft
DE60036935D1 (de) Diagnostisches Verfahren für Eierstock- und Endometriumtumore basierend auf dem Nachweis des L1-Adhäsionsmoleküls
AU2001257313A1 (en) Method and apparatus for the detection and diagnosis of cancer, specifically breast cancer using diffusion mri
WO2002006515A3 (en) Method of diagnosing, monitoring, staging, imaging and treating colon cancer
ATE423852T1 (de) Methoden zur diagnose und prognose von krebs
ATE546544T1 (de) Verfahren zur diagnose und behandlung von lungenkrebs
ATA19972000A (de) Pibf für die diagnose von tumoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties